Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 1 Interventional

A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT06179069

Public ClinicalTrials.gov record NCT06179069. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 4:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Multicenter Study of ZL-1310 to Evaluate the Safety, Efficacy, and Pharmacokinetics in Participants With Small Cell Lung Cancer

Study identification

NCT ID
NCT06179069
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Zai Lab (Shanghai) Co., Ltd.
Industry
Enrollment
339 participants

Conditions and interventions

Conditions

Interventions

  • ZL-1310 Drug
  • Atezolizumab Drug
  • Carboplatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 22, 2024
Primary completion
May 29, 2027
Completion
Jul 30, 2027
Last update posted
Jul 22, 2026

2024 – 2027

United States locations

U.S. sites
11
U.S. states
11
U.S. cities
11
Facility City State ZIP Site status
Zai Lab Site 2005 Duarte California 91010 Recruiting
Zai Lab Site 2030 New Haven Connecticut 06519 Recruiting
Zai Lab Site 2026 Sarasota Florida 34232 Recruiting
Zai Lab Site 2013 Detroit Michigan 48201 Recruiting
Zai Lab Site 2001 Hackensack New Jersey 07601 Recruiting
Zai Lab Site 2002 Buffalo New York 14263 Recruiting
Zai Lab Site 2018 Durham North Carolina 27710 Recruiting
Zai Lab Site 2024 Cleveland Ohio 44106 Recruiting
Zai Lab Site 2029 Pittsburgh Pennsylvania 15232 Not yet recruiting
Zai Lab Site 2012 Charleston South Carolina 29425 Recruiting
Zai Lab Site 2006 Fairfax Virginia 22031 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06179069, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 22, 2026 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06179069 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →